Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation
Pacing and Clinical Electrophysiology · 2024
DOI: 10.1111/pace.15051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2024. Verfasst von Raheel Ahmed und 17 weiteren Autor:innen. Beteiligte Einrichtung: Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Sarcoidosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation.
Methods
The 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs.
Results
Among 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p < .01), had higher rates of diabetes (31.7% vs. 21.6%, p < .01) and chronic kidney disease (CKD) (16.8% vs. 7.8%, p < .01) but lower prevalence of atrial fibrillation (AF) (11.9% vs. 23.5%, p < .01), sick sinus syndrome (4.0% vs. 7.8%, p = .024), ventricular fibrillation (VF) (9.9% vs. 15.7%, p = .02), and black ancestry (31.9% vs. 58.0%, p < .01). Unadjusted major adverse cardiovascular events (MACE), defined as a composite of in‐hospital death, myocardial infarction (MI), and ischemic stroke, was higher in females (11.8% vs. 6.9%, p = .024), but when adjusted for age and tCharlson Comorbidity Index (CCI), females demonstrated significantly lower odds of experiencing MACE (aOR: 0.048, 95% CI: 0.006–0.395, p = .005). Incidence of acute kidney injury (AKI) post‐ICD was significantly lower in females (15.7% vs. 23.8%, p = .01) as was the adjusted odds (aOR: 0.282, 95% CI: 0.146–0.546, p < .01). There was comparable mean length of stay and hospital charges.
Conclusion
ICD utilization in CS patients is more common among males, who have a higher prevalence of diabetes and CKD but a lower prevalence of AF, sick sinus syndrome, and VF. Adjusted MACE and AKI were significantly lower in females.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK.
- National Heart and Lung Institute, Imperial College London, London, UK.
- Dow University of Health Sciences, Karachi, Pakistan.
- Independent Researcher, Triolet, Mauritius.
- Northumbria Hospitals, NHS Foundation Trust, Newcastle upon Tyne, UK.
- Abington Hosp- Jefferson Health, Horsham, USA.
ORCID-Profile: Raheel Ahmed
Zitieren
APA
Ahmed, R., Jamil, Y., Ramphul, K., Mactaggart, S., Bilal, M., Singh Dulay, M., Shi, R., Azzu, A., Okafor, J., Memon, R. A., Sakthivel, H., Khattar, R., Wells, A. U., Baksi, J. A., Wechalekar, K., Kouranos, V., Chahal, A., & Sharma, R. (2024). Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.15051
Vancouver
Ahmed R, Jamil Y, Ramphul K, Mactaggart S, Bilal M, Singh Dulay M, et al. Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation. Pacing and Clinical Electrophysiology. 2024. doi:10.1111/pace.15051
BibTeX
@article{Ahmed2024,
author = {Ahmed, Raheel and Jamil, Yumna and Ramphul, Kamleshun and Mactaggart, Sebastian and Bilal, Maham and Singh Dulay, Mansimran and Shi, Rui and Azzu, Alessia and Okafor, Joseph and Memon, Rahat A and Sakthivel, Hemamalini and Khattar, Rajdeep and Wells, Athol Umfrey and Baksi, John Arun and Wechalekar, Kshama and Kouranos, Vasilis and Chahal, Anwar and Sharma, Rakesh},
title = {Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
doi = {10.1111/pace.15051}
}
EUVIMED